TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Navidea Biopharmaceuticals Inc (NYSE:NAVB) Investor Investigation Over Possible Breaches Of Fiduciary Duties Announced

  • If you are a current long-term stockholder of shares of Navidea Biopharmaceuticals Inc (NYSE:NAVB), you have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Navidea Biopharmaceuticals Inc
Security
AMEX: NAVB

Summary

June 19, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) was announced concerning whether certain Navidea Biopharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.

The investigation by a law firm concerns whether certain Navidea Biopharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders by, among other things, failing to implement adequate internal controls.

Shares of Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) rose from $0.55 in April 2009 to as high as $5.26 in May 2011, respectively $4.66 per share in July 2012.

Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) reported that its Net Income of $5.61 million in 2011 declined to a Net Loss of $29.16 million.

June 18, 2013, NYSE:NAVB shares closed at $2.66 per share.

Start Monitoring Your Investments